Advisor Group’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$252K Sell
10,714
-2,607
-20% -$58.4K ﹤0.01% 2205
2019
Q3
$240K Sell
13,321
-11,238
-46% -$186K ﹤0.01% 2183
2019
Q2
$385K Sell
24,559
-1,081
-4% -$21.3K ﹤0.01% 1798
2019
Q1
$584K Buy
25,640
+1,225
+5% +$27.6K ﹤0.01% 1479
2018
Q4
$568K Sell
24,415
-9,818
-29% -$262K 0.01% 1316
2018
Q3
$1.13M Buy
34,233
+4,325
+14% +$162K 0.01% 906
2018
Q2
$1.32M Sell
29,908
-494
-2% -$19.1K 0.02% 729
2018
Q1
$1.27M Sell
30,402
-15,684
-34% -$724K 0.02% 744
2017
Q4
$2.1M Buy
46,086
+4,909
+12% +$193K 0.03% 548
2017
Q3
$1.36M Buy
41,177
+16,333
+66% +$665K 0.02% 664
2017
Q2
$1.01M Buy
24,844
+179
+0.7% +$5.55K 0.02% 750
2017
Q1
$497K Sell
24,665
-7,486
-23% -$158K 0.01% 1078
2016
Q4
$741K Sell
32,151
-3,692
-10% -$79.1K 0.02% 791
2016
Q3
$727K Buy
35,843
+9,963
+38% +$201K 0.02% 782
2016
Q2
$485K Buy
+25,880
New +$476K 0.01% 937

Other funds holding PETS

Advisor Group's PETS Position: Q4 2019 in Review

Advisor Group reduced its PetMed Express (PETS) stake by 20% in Q4 2019, selling an estimated $58.4K and leaving 10,714 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2205.

Advisor Group first reported a position in PETS in Q2 2016 and has held it in 15 quarters since. The position peaked at $2.1M in Q4 2017. 189 funds tracked by Wall St. Rank hold PETS as of Q4 2019.

  • Advisor Group held 10,714 shares of PetMed Express worth $252K as of Q4 2019.
  • Advisor Group sold 2,607 PetMed Express shares in Q4 2019, an estimated $58.4K.
  • PetMed Express made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2205 holding.
  • Advisor Group first reported a position in PetMed Express in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's PetMed Express position peaked at $2.1M in Q4 2017.
  • 189 funds tracked by Wall St. Rank held PetMed Express as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.